266 related articles for article (PubMed ID: 2529311)
21. Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis.
Sherr E; Macy E; Kimata H; Gilly M; Saxon A
J Immunol; 1989 Jan; 142(2):481-9. PubMed ID: 2521348
[TBL] [Abstract][Full Text] [Related]
22. Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors.
Bujanowski-Weber J; Brings B; Knöller I; Pfeil T; König W
Immunology; 1989 Apr; 66(4):505-11. PubMed ID: 2523859
[TBL] [Abstract][Full Text] [Related]
23. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.
Richard Y; Leprince C; Dugas B; Treton D; Galanaud P
J Immunol; 1987 Sep; 139(5):1563-7. PubMed ID: 3114370
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a human B cell line that responds specifically to B cell growth factor.
Zhu LP; Shi L; Zheng DI; Guo BC; Wang X; Zhang SZ
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(2):69-74. PubMed ID: 2243835
[TBL] [Abstract][Full Text] [Related]
25. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
Brooks KH; Vitetta ES
J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
[TBL] [Abstract][Full Text] [Related]
26. Role of PAF and cytokines in the modulation of Fc epsilon RII/CD23 expression on human eosinophils.
Kawabe T; Maeda Y; Maekawa N; Tanaka M; Mayumi M; Mikawa H; Yodoi J
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():989-95. PubMed ID: 1825444
[TBL] [Abstract][Full Text] [Related]
27. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C
Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide "dual pathway" of signalling.
Gordon J; Cairns JA; Millsum MJ; Gillis S; Guy GR
Eur J Immunol; 1988 Oct; 18(10):1561-5. PubMed ID: 2847932
[TBL] [Abstract][Full Text] [Related]
29. Isolation, characterization, and expression of cDNA clones encoding the mouse Fc receptor for IgE (Fc epsilon RII)1.
Gollnick SO; Trounstine ML; Yamashita LC; Kehry MR; Moore KW
J Immunol; 1990 Mar; 144(5):1974-82. PubMed ID: 2137845
[TBL] [Abstract][Full Text] [Related]
30. Influence of interleukin-4 and platelet-activating factor on the Fc epsilon RII/CD23 expression on human monocytes.
Paul-Eugène N; Dugas B; Picquot S; Lagente V; Mencia-Huerta JM; Braquet P
J Lipid Mediat; 1990; 2(2):95-101. PubMed ID: 2152043
[TBL] [Abstract][Full Text] [Related]
31. Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes.
Katira A; Kamal M; Gordon J
Immunology; 1992 Jul; 76(3):422-6. PubMed ID: 1388135
[TBL] [Abstract][Full Text] [Related]
32. Human B cell proliferation in response to IL-4 is associated with enhanced production of B cell-derived growth factors.
Tadmori W; Lee HK; Clark SC; Choi YS
J Immunol; 1989 Feb; 142(3):826-32. PubMed ID: 2783602
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory influence of IL-4 on human B cell responsiveness.
Jelinek DF; Lipsky PE
J Immunol; 1988 Jul; 141(1):164-73. PubMed ID: 2837507
[TBL] [Abstract][Full Text] [Related]
34. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
35. B cell activator. Effects on B cell expression of CD23, proliferation, and antibody secretion.
Marcelletti JF; Matsushita S; Katz DH
J Immunol; 1992 Jun; 148(12):3857-63. PubMed ID: 1318334
[TBL] [Abstract][Full Text] [Related]
36. B cell growth-promoting activity of recombinant human interleukin 4.
Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
[TBL] [Abstract][Full Text] [Related]
37. Effect of cytokines on spontaneous and allergen-induced CD23 expression, sCD23 release and Ig(E,G) synthesis from peripheral blood lymphocytes.
Pfeil T; Fischer A; Bujanowski-Weber J; Luther H; Altmeyer P; König W
Immunology; 1989 Sep; 68(1):37-44. PubMed ID: 2530155
[TBL] [Abstract][Full Text] [Related]
38. IL-2 receptor and Fc epsilon R2 gene activation in lymphocyte transformation: possible roles of ATL-derived factor.
Yodoi J; Tagaya Y; Masutani H; Maeda Y; Kawabe T
Princess Takamatsu Symp; 1988; 19():73-86. PubMed ID: 2978620
[TBL] [Abstract][Full Text] [Related]
39. CD20 monoclonal antibodies decrease interleukin-4-stimulated expression of the low-affinity receptor for IgE (Fc epsilon RII/CD23) in human B cells by increasing the extent of its cleavage.
Bourget I; Di Berardino W; Breittmayer JP; Grenier-Brossette N; Plana-Prades M; Bonnefoy JY; Cousin JL
Eur J Immunol; 1995 Jul; 25(7):1872-6. PubMed ID: 7542593
[TBL] [Abstract][Full Text] [Related]
40. The Ba fragment of complement factor B inhibits human B lymphocyte proliferation.
Ambrus JL; Peters MG; Fauci AS; Brown EJ
J Immunol; 1990 Mar; 144(5):1549-53. PubMed ID: 2307833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
